21. Lifeclinic.com - Home Lifeclinic hypertension, Cholesterol, Stroke and Preeclampsia resource.On-line tracking of blood pressure, cholesterol, pulse and weight measurements. http://www.lifeclinic.com/

Key Word Search My Health Record FREE Blood Pressure Health Station Locator For Physicians ... Dietwatch Login Whether you are managing a serious chronic condition or looking for ways to improve your overall health and well-being, lifeclinic.com is here to help. From expert tips to healthy recipes to health stations to unique charting and tracking tools, rely on lifeclinic.com to provide the solutions you need to take better care of yourself. Free Health Email Newsletter Sign up today and begin receiving your weekly newsletter Awards Term of Use PAGE OPTIONS Bookmark Printer Friendly Format Email This Page eCard CONTACT Comments Technical Help Try the lifeclinic.com Health Chart today. Take a tour! NEWS THIS WEEK from lifeclinic.com Select your topic of interest Easy-to-use calculators for body mass index, calories intake, ideal body weight, and many more lifeclinic.com invites you to participate in our new Lifeclinic Online Poll, which focuses on various interactive features. Keep track and be reminded of your many routine care events

22. THE MERCK MANUAL--SECOND HOME EDITION, Portal Hypertension In Ch. 135, Clinical Explains what it is, causes, symptoms and treatment. http://www.merck.com/mmhe/sec10/ch135/ch135e.html

var externalLinkWarning = "The link you have selected will take you to a site outside Merck and The Merck Manuals.*n*nThe Merck Manuals do not review or control the content of any non-Merck site. The Merck Manuals do not endorse and are not responsible for the accuracy, content, practices, or standards of any non-Merck sources."; Search The Second Home Edition , Online Version Search Index A B C D ... Z Sections Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders ... Women's Health Issues Resources Anatomical Drawings Multimedia Pronunciations Weights and Measures ... , Online Version Section Liver and Gallbladder Disorders Chapter Clinical Manifestations of Liver Disease Topics Introduction Ascites Cholestasis Enlargement of the Liver ... Liver Failure Portal Hypertension Portal Hypertension Buy The Book Print This Topic Email This Topic Pronunciations ascites cholestasis cirrhosis computed tomography ... vasopressin Portal hypertension is abnormally high blood pressure in branches of the portal vein, the large vein that brings blood from the intestines to the liver. The portal vein receives blood drained from the entire intestine and from the spleen, pancreas, and gallbladder. After entering the liver, the vein divides into right and left branches and then into tiny channels that run through the liver. When blood leaves the liver, it drains back into the general circulation through the hepatic vein (see

23. Hypertension Understanding hypertension treatment is essential to understanding the causes of high blood pressure. This page defines hypertension and describes http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

24. Société Québécoise D'Hypertension Artérielle Informations g©n©rales, et acc¨s   des pages r©serv©es, accessibles apr¨s inscription. http://www.hypertension.qc.ca/

window.resizeTo(790,720); window.resizeTo(790,760); xxxxx Pour les utilisateurs Macintosh, il est recommend© d'utiliser ou sup©rieur

25. What Is Hypertension? hypertension, the medical name given to high blood pressure, is defined in an adult as a blood pressure greater than or equal to 140 mm Hg systolic http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

26. FDA Approves First Oral Medication For Pulmonary Arterial Hypertension Describes the trial results and subsequent approval of Tracleer. http://www.fda.gov/bbs/topics/ANSWERS/2001/ANS01121.html

FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest. Talk Papers are subject to change as more information becomes available. Print Media: 301-827-6242 November 20, 2001 Consumer Inquiries: 888-INFO-FDA FDA APPROVES FIRST ORAL MEDICATION FOR PULMONARY ARTERIAL HYPERTENSION Pulmonary arterial hypertension (PAH) is defined as abnormally high blood pressure in the arteries between the heart and lungs. PAH significantly reduces the ability of patients to exert themselves physically without becoming short of breath. PAH significantly shortens the life span of patients because it leads to heart failure. Tracleer blocks the action of endothelin, a substance made by the body. Endothelin narrows blood vessels and elevates blood pressure. Although endothelin is present in healthy people, high concentrations of the hormone have been found in the plasma and lungs of patients with PAH suggesting it is capable of causing the disease. The use of Tracleer requires attention to two significant risks: liver toxicity and the drug's potential to damage a fetus. In order to ensure careful attention to monitoring for these risks, Tracleer will be available only through a direct distribution program from the drug's manufacturer, Actelion Pharmaceuticals US, Inc., of South San Francisco, Calif. It will not be available in commercial pharmacies.

27. Hypertension Or High Blood Pressure - CardiologyChannel Hypertention (HTN), or high blood pressure has a high incidence throughout the world. Over half of all persons age 65 and older develop hypertension . http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

28. PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN A definition along with look at the diagnosis, treatment and the prognosis, from the University of Washington Academic Medical Center. http://neonatal.peds.washington.edu/NICU-WEB/pphn.stm

University of Washington Academic Medical Center Children's Hospital and Regional Medical Center Persistent Pulmonary Hypertension Of The Newborn Authors References Created Reviewed Revised Table of Contents Nomenclature Definition Changes in Pulmonary Circulation at Birth Pathophysiology ... Outcome Nomenclature Persistent pulmonary hypertension of the newborn is a cardiopulmonary disorder characterized by systemic arterial hypoxemia secondary to elevated pulmonary vascular resistance with resultant shunting of pulmonary blood flow to the systemic circulation. This pathophysiologic syndrome has been variously described as: Persistent pulmonary vascular obstruction Persistent fetal circulation Pulmonary vasospasm Neonatal pulmonary ischemia Persistent transitional circulation Definition Persistent pulmonary hypertension of the newborn (PPHN) is the result of elevated pulmonary vascular resistance to the point that venous blood is diverted to some degree through fetal channels (i. e. the ductus arteriosus and foramen ovale) into the systemic circulation and bypassing the lungs, resulting in systemic arterial hypoxemia. This disorder can be classified into three forms dependent on the likely etiology of the pulmonary hypertension: PPHN associated with pulmonary parenchymal disease , such as hyaline membrane disease, meconium aspiration, or transient tachypnea of the newborn as the cause of alveolar hypoxia known as secondary PPHN or appropriate PPHN alveolar oxygen tension appears to be the major determinant of pulmonary artery vasoconstriction.

29. American Heart Association Information and education about heart and stroke disease. http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

30. HDCN -- Topic Index: Hypertension Heart in hypertension. End Organ Damage. Kidney in hypertension. Intracellular ioniccomposition. Calcium. Salt (sodium, chloride) sensitivity http://www.hdcn.com/fhh.htm

Topic Index: Hypertension H: Pathophysiology Age-related norms Heart in hypertension End Organ Damage Kidney in hypertension Intracellular ionic composition Calcium Salt (sodium, chloride) sensitivity Sleep, sleep apnea Sympathetic nervous system Hormonal aberrations Coagulation abnormalities Genetics Vascular pathology Endothelium, Nitric Oxide Fetal origins, birth weight Stroke H: Exam and lab tests Arm cuff Ambulatory monitoring White coat hypertension Tests for LVH Tests for early atherosclerosis H: Diagnosis Preadolescent and adolescent Young adult through middle age Elderly H: Special problems Women Outcomes Patients with lipid disorders Endocrine hypertension Pheochromocytoma Renovascular hypertension Renal transplant patients Ethnic populations Chronic renal insufficiency Drug-induced hypertension Hypercalciuria Smoking, ethanol, substance abuse Obesity, Insulin Resistance Dialysis patients Elderly H: Drug therapy Calcium channel blockers ACE inhibitors Diuretics Beta blockers Alpha and alpha/beta blockers Sympatholytics Vasodilators Other drugs Compliance Cost-effectiveness Chronotherapeutics Multiple drugs, synergy

31. Page Not Found Abstracts covering the role of various nutrients in hypertension and related diseases. http://lef.org/protocols/abstracts/abstr-060c.html

var WebSiteBaseURL = "http://www.lef.org" var ThisPageFullURL = "http://www.lef.org" translation by SYSTRAN MEMBERSHIP PRODUCTS MAGAZINE ... Security We're sorry, the page you are requesting has been moved or may no longer exist. Please check the spelling of the URL to make sure that the address is correct. Home Membership Products Magazine ... Site Map document.write("The information provided on this site is "); document.write("for informational purposes only and is not intended as a substitute for advice "); document.write("from your physician or other health care professional or any information "); document.write("contained on or in any product label or packaging. You should not use the "); document.write("information on this site for diagnosis or treatment of any health problem or "); document.write("for prescription of any medication or other treatment. You should consult with "); document.write("a healthcare professional before starting any diet, exercise or supplementation "); document.write("program, before taking any medication, or if you have or suspect you might have "); document.write("a health problem. You should not stop taking any medication without first "); document.write("consulting your physician.");

32. High Blood Pressure (hypertension) - Causes, Treatments And High Blood Pressure Medical information about hypertension, its treatment, therapies and prevention http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

33. Management Of Chronic Hypertension During Pregnancy: Summary - Redirect Article discussing treatment, possible complications, and monitoring techniques. http://www.ahcpr.gov/clinic/pregsum.htm

The summary of Evidence Report/Technology Assessment Number 14: Management of Chronic Hypertension During Pregnancy has been moved. It is now at: www.ahrq.gov/clinic/epcsums/pregsum.htm Please update your bookmarks. AHRQ Home Page

34. ScienceDirect - American Journal Of Hypertension - List Of Issues Redirect BHSThe British hypertension society pages are now located at British hypertensionSociety. Please update your books to reflect the change. Webmaster http://www.sciencedirect.com/science/journal/08957061

Register or Login: Password: Athens/Institution Login Quick Search: within This Journal All Journals All Full-text Sources American Journal of Hypertension Bookmark this page as: http://www.sciencedirect.com/science/journal/08957061 Volume 18 Volume 18, Issue 9, Supplement 1 , Pages 125-162 (September 2005) Pharmacological Modulation of the Renin-Angiotensin System in Hypertension: - Making the Right Choice Volume 18, Issue 8 , Pages 1017-1138 (August 2005) Volume 18, Issue 7 , Pages 893-1016 (July 2005) Volume 18, Issue 6 , Pages 739-891 (June 2005) Volume 18, Issue 5 , Pages 577-737 (May 2005) Volume 18, Issue 5, Supplement 1 , Pages A1-A269 (May 2005) 20th Annual Scientific Meeting Volume 18, Issue 4 , Pages 443-575 (April 2005) Volume 18, Issue 4, Supplement 1 , Pages 93-124 (April 2005) Volume 18, Issue 3 , Pages 297-441 (March 2005) Volume 18, Issue 2 , Pages 149-296 (February 2005) Volume 18, Issue 2, Supplement 1 , Pages 23-91 (February 2005) Volume 18, Issue 1 , Pages 1-147 (January 2005) Volume 18, Issue 1, Supplement 1 , Pages 1-22 (January 2005) Volume 17 Volume 16 Volume 15 Volume 14 ... Volume 8 Alert me when new Journal Issues are available Add this journal to My Favorite Journals Sample Issue Online More Publication Info Information for Authors Contact Us ... Elsevier B.V.

35. Kidney Health General kidney information, disease treatment and prevention. Covers related topics of diabetes, hypertension and nutrition. http://www.medbroadcast.com/channel_main.asp?channel_id=1021

36. High Blood Pressure Mild cases of hypertension can be treated through behavior modification like More severe cases of hypertension require medications like diuretics and http://sln.fi.edu/biosci/healthy/pressure.html

Hypertension There is no "ideal" blood pressure reading. However, there is a range of "normal" blood pressure reading. Generally, a reading that is less than 140 over 90 indicates that you don't need to worry. If either or both numbers are equal to or greater than 140 over 90 for an extended period of time, you have high blood pressure, or hypertension. Hypertension is dangerous because it causes the heart to work extra hard. This strain contributes to heart attacks and stroke. When the heart is forced to work extra hard for an extended period of time, it tends to enlarge. A slightly enlarged heart can function well, but a significantly enlarged heart cannot. High blood pressure also causes damage to the arteries, causing arterial disease Hypertension can be treated. Mild cases of hypertension can be treated through behavior modification like changing diet and increasing exercise . More severe cases of hypertension require medications like diuretics and beta blockers. Diuretics rid the body of excess fluids and salt. Beta blockers reduce the heart rate and the heart's output of blood. Understanding Hypertension American Society of Hypertension Back to Heart Disease

37. N C H S - FASTATS - Hypertension bullet graphic Percent of residents with hypertension 26.4 (1999). bullet graphicAverage length of stay for discharges with hypertension as primary http://www.cdc.gov/nchs/fastats/hyprtens.htm

A B C D ... I J K L M N ... P Q R S T U ... W X Y Z Faststats Home NCHS Home Accessibility Search NCHS ... Contact us Hypertension (Data are for U.S. for year in parentheses) Morbidity Percent of non-institutionalized adults ages 20 and over: 30.1 (1999-2002) Source Health, United States, 2004, table 67 Health care use Ambulatory care Number of visits to office-based physicians: 17.2 million (2002) Source: National Ambulatory Medical Care Survey: 2002 Summary Number of hospital outpatient department visits: 1.2 million (2002) Source: National Hospital Ambulatory Medical Care Survey: 2002 Outpatient Summary Home health care Number of current patients with hypertension as primary diagnosis: 41,900 (2000) Percent of current patients with hypertension as primary diagnosis: 3.1 Source: National Home and Hospice Care Survey Nursing home care Number of residents with hypertension: 481,800 (1999) Percent of residents with hypertension: 26.4 (1999) Average length of stay for discharges with hypertension as primary diagnosis: 494 days Source: National Nursing Home Survey: 1999 Summary Mortality Number of deaths: 20,261 (2002)

38. Virtual Hospital: Adult Pulmonary Core Curriculum: COPD With Pulmonary Hypertens A discussion about treatments including betaagonist inhalers, anticholinergic inhalers, theophylline, corticosteroids and other therapies. http://www.vh.org/Providers/TeachingFiles/PulmonaryCoreCurric/COPD/Treatment.htm

Adult Pulmonary Core Curriculum: COPD with Pulmonary Hypertension and Cor Pulmonale Treatment of COPD Written by: Michael W. Peterson, M.D. Joel N. Kline, M.D. Charles Dayton, B.S., R. Ph. Elizabeth Beltz, Pharm. D., R. Ph. Peer Review Status: Externally Reviewed by the Department of Internal Medicine Virtual Hospital Editorial Board Pharmacological COPD treatment should be individualized to maximize benefit and minimize side effects of the medications. The American Thoracic Society recently suggested defining the severity of COPD based on spirometry and designing treatment based on disease severity (1). Regardless of severity, the therapeutic goal is bronchodilation, reducing inflammation, and facilitating expectoration. In patients with mild disease, this can be attained using intermittent inhaled beta agonist drugs. A trial of steroids may also be considered with monitoring for objective response as outlined below. Additional treatment decisions should be based on symptoms and response to treatment. A description of the drug classes available follows. Short and long-acting beta-agonist inhalers: These metered dose inhaled beta-agonist bronchodilators are the mainstay of treatment for COPD. However, the most appropriate dosing and dosing intervals have not been extensively studied. Most patients use the short acting inhalers at two puffs four daily, either scheduled or as needed. New, long-acting formulations might be useful when administered at bedtime to patients who report nocturnal symptoms. It is important to remember that the response to bronchodilators on spirometry does not identify all patients who will benefit from these agents. Clinical response should guide the use of the medication. Patients must use the metered dose inhalers appropriately to benefit, and instructions on the proper use of aerosol inhalers is mandatory for maximal effect. The National Asthma Education Program has published guidelines to aid health care professionals in

39. Pulmonary Hypertension Fact Sheet | CVH Program Pulmonary hypertension is a rare lung disorder in which the blood pressure in the Pulmonary hypertension may develop after pregnancy, hypothyroidism, http://www.cdc.gov/cvh/library/fs_pulmonary_hypertension.htm

Home Contact Us Program Activities Announcements ... Fact Sheets Pulmonary Hypertension Fact Sheet This document is also available in Portable Document Format (PDF - 59K) Learn more about PDFs Annual number of hospitalizations among persons with pulmonary hypertension, United States, 1985–1998 Source: CDC, National Hospital Discharge Survey. [A text version of this graphic is also available.] Facts on Pulmonary Hypertension Pulmonary hypertension is a rare lung disorder in which the blood pressure in the pulmonary artery rises far above normal levels, usually with no apparent reason. Symptoms include chronic fatigue, shortness of breath (dyspnea), chest pain (angina), fainting, swollen ankles and legs (edema), and fluid in the abdomen (ascites). These are also symptoms for other diseases such as congestive heart failure; therefore, physicians should rule out other diseases before making a diagnosis of pulmonary hypertension. Pulmonary hypertension may develop after pregnancy, hypothyroidism, pulmonary embolism, autoimmune disorders, or human immunodeficiency virus (HIV) infection or result from the use of drugs such as appetite suppressants, oral contraceptives, and cocaine.

40. Page Not Found [NEI] Designed to determine if using eyedrop medicines to lower eye pressure prevents or delays glaucoma in people with high eye pressure. http://www.nei.nih.gov/glaucomaeyedrops/ohts_backg.htm

Text size: S M L Health Funding News Laboratories ... Home Sorry, that page cannot be found. We recently updated our website, and some pages have moved or have new names. Please go to our home page , and then follow links to the information you want. Thank you. This page was last modified in October 2004 NEI Home Contact Us Health Funding ... Accessibility We welcome your questions and comments. Please send general questions and comments to the NEI Office of Communication, Health Education, and Public Liaison . Technical questions about this website can be addressed to the NEI Website Manager d d National Eye Institute 2020 Vision Place Bethesda, MD 20892-3655 www.nei.nih.gov

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 2     21-40 of 186    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8  | 9  | 10  | Next 20